speb/financial-data huggingface dataset:
RXL.PA balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 165700000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 912800000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 912800000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Minority Interest: 11500000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Minority Interest: 11500000.00
RXL.PA income_statement (annual, 2025-12-31) — Minority Interests: -2500000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -256700000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -96600000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Net Debt: 2568200000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Net Debt: 2568200000.00
RXL.PA income_statement (annual, 2025-12-31) — Net Income: 588900000.00
RXL.PA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 588900000.00
RXL.PA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 591400000.00
RXL.PA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 588900000.00
RXL.PA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 588900000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 1061600000.00
RXL.PA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 591400000.00
RXL.PA income_statement (annual, 2025-12-31) — Net Interest Income: -218900000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -7800000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 489000000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 489000000.00
RXL.PA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -218900000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -100000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 100000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Net PPE: 1695900000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Net PPE: 1695900000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -136300000.00
RXL.PA cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -88300000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -172800000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -172800000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 30700000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 30700000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 309400000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 309400000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 100100000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 100100000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 58600000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 58600000.00
RXL.PA income_statement (annual, 2025-12-31) — Normalized EBITDA: 1544200000.00
RXL.PA income_statement (annual, 2025-12-31) — Normalized Income: 660892800.00
RXL.PA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 795800000.00
RXL.PA income_statement (annual, 2025-12-31) — Operating Income: 1126500000.00
RXL.PA income_statement (annual, 2025-12-31) — Operating Revenue: 19414600000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 293205756.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 293205756.00
RXL.PA balance_sheet (annual, 2025-12-31) — Other Current Assets: 100000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 100000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 365200000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 365200000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1659300000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1659300000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Other Inventories: 2499300000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Other Inventories: 2499300000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Other Investments: 1500000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Other Investments: 1500000.00
RXL.PA cash_flow (annual, 2025-12-31) — Other Non Cash Items: -87800000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 23000000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 23000000.00
RXL.PA income_statement (annual, 2025-12-31) — Other Operating Expenses: 169700000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Other Payable: 254600000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Other Payable: 254600000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Other Properties: 177400000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Other Properties: 177400000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Other Receivables: 824600000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Other Receivables: 824600000.00
RXL.PA income_statement (annual, 2025-12-31) — Other Special Charges: -40500000.00
RXL.PA income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
RXL.PA balance_sheet (annual, 2025-12-31) — Payables: 2511100000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Payables: 2511100000.00
RXL.PA cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: -2400000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 355100000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 355100000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Prepaid Assets: 43400000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 43400000.00
RXL.PA income_statement (annual, 2025-12-31) — Pretax Income: 847400000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Properties: 0.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
RXL.PA cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 6700000.00
RXL.PA cash_flow (annual, 2025-12-31) — Purchase Of Business: -330900000.00
RXL.PA cash_flow (annual, 2025-12-31) — Purchase Of PPE: -145500000.00
RXL.PA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 14541400000.00
RXL.PA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 436800000.00
RXL.PA income_statement (annual, 2025-12-31) — Rent And Landing Fees: 151300000.00
RXL.PA income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 151300000.00
RXL.PA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -88300000.00
RXL.PA income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 51900000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Retained Earnings: 3663200000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 3663200000.00
RXL.PA cash_flow (annual, 2025-12-31) — Sale Of Business: 74200000.00
RXL.PA cash_flow (annual, 2025-12-31) — Sale Of PPE: 9200000.00
RXL.PA income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 349800000.00
RXL.PA income_statement (annual, 2025-12-31) — Selling General And Administration: 763500000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Share Issued: 296096004.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Share Issued: 296096004.00
RXL.PA income_statement (annual, 2025-12-31) — Special Income Charges: -64900000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Stockholders Equity: 5394200000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 5394200000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Tangible Book Value: -172800000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -172800000.00
RXL.PA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -19207200.00
RXL.PA income_statement (annual, 2025-12-31) — Tax Provision: 256000000.00
RXL.PA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.30
RXL.PA balance_sheet (annual, 2025-12-31) — Taxes Receivable: 59600000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 59600000.00
RXL.PA cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -270600000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Total Assets: 14366600000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Total Assets: 14366600000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Total Capitalization: 8328500000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 8328500000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Total Debt: 5094000000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Total Debt: 5094000000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 5405700000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 5405700000.00
RXL.PA income_statement (annual, 2025-12-31) — Total Expenses: 18288100000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 8960900000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 8960900000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 7355200000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 7355200000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 4807400000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 4807400000.00
RXL.PA income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1061600000.00
RXL.PA income_statement (annual, 2025-12-31) — Total Other Finance Cost: 5300000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Total Tax Payable: 85600000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 85600000.00
RXL.PA income_statement (annual, 2025-12-31) — Total Unusual Items: -36000000.00
RXL.PA income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -63600000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 9200000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 9200000.00
RXL.PA balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 2890248.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 2890248.00
RXL.PA balance_sheet (annual, 2025-12-31) — Working Capital: 2857800000.00
RXL.PA balance_sheet (quarterly, 2025-12-31) — Working Capital: 2857800000.00
RXL.PA income_statement (annual, 2025-12-31) — Write Off: 25900000.00
RXO income_statement (annual, 2021-12-31) — Depreciation Amortization Depletion Income Statement: 81000000.00
RXO income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 81000000.00
RXO income_statement (annual, 2021-12-31) — Gain On Sale Of Business: -2000000.00
RXO income_statement (annual, 2021-12-31) — General And Administrative Expense: 2000000.00
RXO balance_sheet (annual, 2021-12-31) — Other Equity Interest: 1072000000.00
RXO income_statement (annual, 2021-12-31) — Other Gand A: 2000000.00
RXO income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -1000000.00
RXO income_statement (annual, 2021-12-31) — Other Operating Expenses: 192000000.00
RXO income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 539000000.00
RXO income_statement (annual, 2022-12-31) — +Operating Expense: 640000000.00
RXO income_statement (annual, 2022-12-31) — +Total Revenue: 4796000000.00
RXO balance_sheet (annual, 2022-12-31) — Accounts Payable: 501000000.00
RXO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 900000000.00
RXO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -241000000.00
RXO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 588000000.00
RXO balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -13000000.00
RXO cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 21000000.00
RXO cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 21000000.00
RXO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
RXO income_statement (annual, 2022-12-31) — Basic Average Shares: 115335000.00
RXO income_statement (annual, 2022-12-31) — Basic EPS: 0.80
RXO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 29000000.00
RXO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 23000000.00
RXO cash_flow (annual, 2022-12-31) — Capital Expenditure: -57000000.00
RXO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 162000000.00
RXO balance_sheet (annual, 2022-12-31) — Capital Stock: 1000000.00
RXO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 98000000.00
RXO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 98000000.00
RXO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -183000000.00
RXO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -56000000.00
RXO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 310000000.00
RXO cash_flow (annual, 2022-12-31) — Change In Account Payable: -14000000.00
RXO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 22000000.00
RXO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 14000000.00
RXO cash_flow (annual, 2022-12-31) — Change In Payable: -14000000.00
RXO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 8000000.00
RXO cash_flow (annual, 2022-12-31) — Change In Receivables: 92000000.00
RXO cash_flow (annual, 2022-12-31) — Change In Working Capital: 114000000.00
RXO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 92000000.00
RXO cash_flow (annual, 2022-12-31) — Changes In Cash: 71000000.00
RXO balance_sheet (annual, 2022-12-31) — Common Stock: 1000000.00
RXO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 587000000.00
RXO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
RXO cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
RXO income_statement (annual, 2022-12-31) — Cost Of Revenue: 3936000000.00
RXO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 256000000.00
RXO balance_sheet (annual, 2022-12-31) — Current Assets: 1029000000.00
RXO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 48000000.00
RXO balance_sheet (annual, 2022-12-31) — Current Debt: 4000000.00
RXO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 52000000.00
RXO balance_sheet (annual, 2022-12-31) — Current Liabilities: 823000000.00
RXO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -20000000.00
RXO cash_flow (annual, 2022-12-31) — Deferred Tax: -20000000.00
RXO cash_flow (annual, 2022-12-31) — Depreciation: 65000000.00
RXO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 86000000.00
RXO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 86000000.00
RXO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 86000000.00
RXO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 86000000.00
RXO income_statement (annual, 2022-12-31) — Diluted Average Shares: 115335000.00
RXO income_statement (annual, 2022-12-31) — Diluted EPS: 0.80
RXO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 92000000.00
RXO income_statement (annual, 2022-12-31) — EBIT: 123000000.00
RXO income_statement (annual, 2022-12-31) — EBITDA: 209000000.00
RXO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -2000000.00
RXO cash_flow (annual, 2022-12-31) — End Cash Position: 98000000.00
RXO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -183000000.00
RXO cash_flow (annual, 2022-12-31) — Free Cash Flow: 253000000.00
RXO income_statement (annual, 2022-12-31) — Gain On Sale Of Business: -84000000.00
RXO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -4000000.00
RXO income_statement (annual, 2022-12-31) — General And Administrative Expense: 84000000.00
RXO balance_sheet (annual, 2022-12-31) — Goodwill: 630000000.00
RXO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 709000000.00
RXO balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 913000000.00
RXO balance_sheet (annual, 2022-12-31) — Gross PPE: 519000000.00
RXO income_statement (annual, 2022-12-31) — Gross Profit: 860000000.00
RXO cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 3000000.00
RXO income_statement (annual, 2022-12-31) — Interest Expense: 4000000.00
RXO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 4000000.00
RXO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
RXO balance_sheet (annual, 2022-12-31) — Invested Capital: 1042000000.00
RXO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -56000000.00
RXO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
RXO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 451000000.00
RXO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 114000000.00
RXO balance_sheet (annual, 2022-12-31) — Long Term Debt: 451000000.00
RXO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 565000000.00
RXO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 451000000.00
RXO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
RXO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 314000000.00
RXO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
RXO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
RXO balance_sheet (annual, 2022-12-31) — Net Debt: 357000000.00
RXO income_statement (annual, 2022-12-31) — Net Income: 92000000.00
RXO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 92000000.00
RXO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 92000000.00
RXO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 92000000.00
RXO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 92000000.00
RXO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 92000000.00
RXO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 92000000.00
RXO income_statement (annual, 2022-12-31) — Net Interest Income: -4000000.00
RXO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 451000000.00
RXO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 451000000.00
RXO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -4000000.00
RXO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -634000000.00
RXO balance_sheet (annual, 2022-12-31) — Net PPE: 278000000.00
RXO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -56000000.00
RXO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -122000000.00
RXO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 16000000.00
RXO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 16000000.00
RXO income_statement (annual, 2022-12-31) — Normalized EBITDA: 306000000.00
RXO income_statement (annual, 2022-12-31) — Normalized Income: 167078000.00
RXO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 310000000.00
RXO income_statement (annual, 2022-12-31) — Operating Income: 220000000.00
RXO income_statement (annual, 2022-12-31) — Operating Revenue: 4796000000.00
RXO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 116400000.00
RXO balance_sheet (annual, 2022-12-31) — Other Current Assets: 31000000.00
RXO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 4000000.00
RXO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 14000000.00
RXO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -4000000.00
RXO income_statement (annual, 2022-12-31) — Other Gand A: 84000000.00
RXO income_statement (annual, 2022-12-31) — Other Income Expense: -97000000.00
RXO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 79000000.00
RXO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 6000000.00
RXO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 15000000.00
RXO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 40000000.00
RXO income_statement (annual, 2022-12-31) — Other Operating Expenses: 226000000.00
RXO balance_sheet (annual, 2022-12-31) — Other Properties: 159000000.00
RXO balance_sheet (annual, 2022-12-31) — Payables: 501000000.00
RXO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 757000000.00
RXO balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
RXO income_statement (annual, 2022-12-31) — Pretax Income: 119000000.00
RXO cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
RXO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -57000000.00
RXO balance_sheet (annual, 2022-12-31) — Receivables: 900000000.00
RXO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 3936000000.00
RXO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 86000000.00
RXO cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
RXO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
RXO income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 97000000.00
RXO balance_sheet (annual, 2022-12-31) — Retained Earnings: 2000000.00
RXO cash_flow (annual, 2022-12-31) — Sale Of PPE: 1000000.00
RXO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 640000000.00
RXO income_statement (annual, 2022-12-31) — Selling General And Administration: 640000000.00
RXO balance_sheet (annual, 2022-12-31) — Share Issued: 116400000.00
RXO income_statement (annual, 2022-12-31) — Special Income Charges: -97000000.00
RXO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 32000000.00
RXO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 587000000.00
RXO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -122000000.00
RXO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -21922000.00
RXO income_statement (annual, 2022-12-31) — Tax Provision: 27000000.00
RXO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
RXO balance_sheet (annual, 2022-12-31) — Total Assets: 2031000000.00
RXO balance_sheet (annual, 2022-12-31) — Total Capitalization: 1038000000.00
RXO balance_sheet (annual, 2022-12-31) — Total Debt: 617000000.00
RXO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 587000000.00
RXO income_statement (annual, 2022-12-31) — Total Expenses: 4576000000.00
RXO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1444000000.00
RXO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1002000000.00
RXO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 621000000.00
RXO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 123000000.00
RXO income_statement (annual, 2022-12-31) — Total Unusual Items: -97000000.00
RXO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -97000000.00
RXO balance_sheet (annual, 2022-12-31) — Working Capital: 206000000.00
RXO income_statement (annual, 2023-12-31) — +Operating Expense: 591000000.00
RXO income_statement (annual, 2023-12-31) — +Total Revenue: 3927000000.00
RXO balance_sheet (annual, 2023-12-31) — Accounts Payable: 414000000.00
RXO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 743000000.00
RXO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -293000000.00
RXO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 590000000.00
RXO balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -12000000.00
RXO cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 13000000.00
RXO cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 13000000.00
RXO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
RXO income_statement (annual, 2023-12-31) — Basic Average Shares: 116871000.00
RXO income_statement (annual, 2023-12-31) — Basic EPS: 0.03
RXO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 98000000.00
RXO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 33000000.00
RXO cash_flow (annual, 2023-12-31) — Capital Expenditure: -64000000.00
RXO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 199000000.00
RXO balance_sheet (annual, 2023-12-31) — Capital Stock: 1000000.00
RXO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 5000000.00
RXO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 5000000.00
RXO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -117000000.00
RXO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -66000000.00
RXO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 89000000.00
RXO cash_flow (annual, 2023-12-31) — Change In Account Payable: -86000000.00
RXO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -60000000.00
RXO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -14000000.00
RXO cash_flow (annual, 2023-12-31) — Change In Payable: -86000000.00
RXO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -146000000.00
RXO cash_flow (annual, 2023-12-31) — Change In Receivables: 158000000.00
RXO cash_flow (annual, 2023-12-31) — Change In Working Capital: -2000000.00
RXO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 158000000.00
RXO cash_flow (annual, 2023-12-31) — Changes In Cash: -94000000.00
RXO balance_sheet (annual, 2023-12-31) — Common Stock: 1000000.00
RXO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 594000000.00
RXO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
RXO cash_flow (annual, 2023-12-31) — Common Stock Payments: -2000000.00
RXO income_statement (annual, 2023-12-31) — Cost Of Revenue: 3269000000.00
RXO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 199000000.00
RXO balance_sheet (annual, 2023-12-31) — Current Assets: 796000000.00
RXO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 53000000.00
RXO balance_sheet (annual, 2023-12-31) — Current Debt: 3000000.00
RXO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 56000000.00
RXO balance_sheet (annual, 2023-12-31) — Current Liabilities: 682000000.00
RXO cash_flow (annual, 2023-12-31) — Deferred Income Tax: -8000000.00
RXO cash_flow (annual, 2023-12-31) — Deferred Tax: -8000000.00
RXO cash_flow (annual, 2023-12-31) — Depreciation: 55000000.00
RXO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 67000000.00
RXO income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 67000000.00
RXO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 67000000.00
RXO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 67000000.00
RXO income_statement (annual, 2023-12-31) — Diluted Average Shares: 119456000.00
RXO income_statement (annual, 2023-12-31) — Diluted EPS: 0.03
RXO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 4000000.00
RXO income_statement (annual, 2023-12-31) — EBIT: 36000000.00
RXO income_statement (annual, 2023-12-31) — EBITDA: 103000000.00
RXO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 1000000.00
RXO cash_flow (annual, 2023-12-31) — End Cash Position: 5000000.00
RXO cash_flow (annual, 2023-12-31) — Financing Cash Flow: -117000000.00
RXO cash_flow (annual, 2023-12-31) — Free Cash Flow: 25000000.00
RXO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -3000000.00
RXO balance_sheet (annual, 2023-12-31) — Goodwill: 630000000.00
RXO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 698000000.00
RXO balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 755000000.00
RXO balance_sheet (annual, 2023-12-31) — Gross PPE: 612000000.00
RXO income_statement (annual, 2023-12-31) — Gross Profit: 658000000.00
RXO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
RXO cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 27000000.00
RXO income_statement (annual, 2023-12-31) — Interest Expense: 32000000.00
RXO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 32000000.00
RXO cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 32000000.00
RXO balance_sheet (annual, 2023-12-31) — Invested Capital: 953000000.00
RXO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -66000000.00
RXO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
RXO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 76000000.00
RXO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 146000000.00
RXO balance_sheet (annual, 2023-12-31) — Long Term Debt: 356000000.00
RXO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 502000000.00
RXO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 76000000.00
RXO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -175000000.00
RXO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 360000000.00
RXO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
RXO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -2000000.00
RXO balance_sheet (annual, 2023-12-31) — Net Debt: 354000000.00
RXO income_statement (annual, 2023-12-31) — Net Income: 4000000.00
RXO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 4000000.00
RXO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 4000000.00
RXO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 4000000.00
RXO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 4000000.00
RXO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 4000000.00
RXO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 4000000.00
RXO income_statement (annual, 2023-12-31) — Net Interest Income: -32000000.00
RXO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -99000000.00
RXO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -99000000.00
RXO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -32000000.00
RXO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -16000000.00
RXO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -2000000.00
RXO balance_sheet (annual, 2023-12-31) — Net PPE: 319000000.00
RXO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -64000000.00
RXO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -104000000.00
RXO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 7000000.00
RXO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 7000000.00
RXO income_statement (annual, 2023-12-31) — Normalized EBITDA: 131000000.00
RXO income_statement (annual, 2023-12-31) — Normalized Income: 32000000.00
RXO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 89000000.00
RXO income_statement (annual, 2023-12-31) — Operating Income: 67000000.00
RXO income_statement (annual, 2023-12-31) — Operating Revenue: 3927000000.00
RXO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 117026000.00
RXO balance_sheet (annual, 2023-12-31) — Other Current Assets: 48000000.00
RXO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 3000000.00
RXO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 13000000.00
RXO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -3000000.00
RXO income_statement (annual, 2023-12-31) — Other Income Expense: -31000000.00
RXO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 68000000.00
RXO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 9000000.00
RXO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 12000000.00
RXO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 40000000.00
RXO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -3000000.00
RXO income_statement (annual, 2023-12-31) — Other Operating Expenses: 235000000.00
RXO balance_sheet (annual, 2023-12-31) — Other Properties: 195000000.00
RXO balance_sheet (annual, 2023-12-31) — Payables: 414000000.00
RXO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 613000000.00
RXO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
RXO income_statement (annual, 2023-12-31) — Pretax Income: 4000000.00
RXO cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
RXO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -64000000.00
RXO balance_sheet (annual, 2023-12-31) — Receivables: 743000000.00
RXO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 3269000000.00
RXO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 67000000.00
RXO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -175000000.00
RXO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -2000000.00
RXO income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 28000000.00
RXO balance_sheet (annual, 2023-12-31) — Retained Earnings: 6000000.00
RXO cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
RXO income_statement (annual, 2023-12-31) — Selling General And Administration: 591000000.00
RXO balance_sheet (annual, 2023-12-31) — Share Issued: 117026000.00
RXO income_statement (annual, 2023-12-31) — Special Income Charges: -28000000.00
RXO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 19000000.00
RXO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 594000000.00
RXO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -104000000.00
RXO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
RXO income_statement (annual, 2023-12-31) — Tax Provision: 0.00
RXO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
RXO balance_sheet (annual, 2023-12-31) — Total Assets: 1825000000.00
RXO balance_sheet (annual, 2023-12-31) — Total Capitalization: 950000000.00
RXO balance_sheet (annual, 2023-12-31) — Total Debt: 558000000.00
RXO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 594000000.00
RXO income_statement (annual, 2023-12-31) — Total Expenses: 3860000000.00
RXO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1231000000.00
RXO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1029000000.00
RXO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 549000000.00
RXO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 39000000.00
RXO income_statement (annual, 2023-12-31) — Total Unusual Items: -28000000.00
RXO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -28000000.00
RXO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
RXO balance_sheet (annual, 2023-12-31) — Working Capital: 114000000.00
RXO balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 45000000.00
RXO cash_flow (quarterly, 2024-09-30) — Common Stock Payments: 0.00
RXO balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 406000000.00
RXO cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 1125000000.00
RXO cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: -17000000.00
RXO cash_flow (quarterly, 2024-09-30) — Repurchase Of Capital Stock: 0.00
RXO cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 84000000.00
RXO cash_flow (quarterly, 2024-09-30) — Short Term Debt Payments: -101000000.00
RXO income_statement (annual, 2024-12-31) — +Operating Expense: 666000000.00
RXO income_statement (annual, 2024-12-31) — +Total Revenue: 4550000000.00
RXO balance_sheet (annual, 2024-12-31) — Accounts Payable: 568000000.00
RXO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 1227000000.00
RXO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -317000000.00
RXO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1904000000.00
RXO balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -13000000.00
RXO cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 28000000.00
RXO cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 17000000.00
RXO cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 28000000.00
RXO cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 17000000.00
RXO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 13000000.00
RXO income_statement (annual, 2024-12-31) — Basic Average Shares: 133412000.00
RXO income_statement (annual, 2024-12-31) — Basic EPS: -2.14
RXO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 5000000.00
RXO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 45000000.00
RXO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 45000000.00
RXO cash_flow (annual, 2024-12-31) — Capital Expenditure: -45000000.00
RXO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 296000000.00
RXO balance_sheet (annual, 2024-12-31) — Capital Stock: 2000000.00
RXO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 35000000.00
RXO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 35000000.00
RXO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 1108000000.00
RXO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1064000000.00
RXO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -12000000.00
RXO cash_flow (annual, 2024-12-31) — Change In Account Payable: -65000000.00
RXO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 117000000.00
RXO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 8000000.00
RXO cash_flow (annual, 2024-12-31) — Change In Payable: -65000000.00
RXO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 52000000.00
RXO cash_flow (annual, 2024-12-31) — Change In Receivables: -109000000.00
RXO cash_flow (annual, 2024-12-31) — Change In Working Capital: -49000000.00
RXO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -109000000.00
RXO cash_flow (annual, 2024-12-31) — Changes In Cash: 32000000.00
RXO balance_sheet (annual, 2024-12-31) — Common Stock: 2000000.00
RXO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1612000000.00
RXO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 1125000000.00
RXO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
RXO cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
RXO cash_flow (quarterly, 2024-12-31) — Common Stock Payments: 0.00
RXO income_statement (annual, 2024-12-31) — Cost Of Revenue: 3854000000.00
RXO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 373000000.00
RXO balance_sheet (annual, 2024-12-31) — Current Assets: 1339000000.00
RXO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 81000000.00
RXO balance_sheet (annual, 2024-12-31) — Current Debt: 17000000.00
RXO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 98000000.00
RXO balance_sheet (annual, 2024-12-31) — Current Liabilities: 1065000000.00
RXO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -19000000.00
RXO cash_flow (annual, 2024-12-31) — Deferred Tax: -19000000.00
RXO cash_flow (annual, 2024-12-31) — Depreciation: 60000000.00
RXO cash_flow (quarterly, 2024-12-31) — Depreciation: 17000000.00
RXO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 87000000.00
RXO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 87000000.00
RXO income_statement (annual, 2024-12-31) — Diluted Average Shares: 133412000.00
RXO income_statement (annual, 2024-12-31) — Diluted EPS: -2.14
RXO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -290000000.00
RXO income_statement (annual, 2024-12-31) — EBIT: -274000000.00
RXO income_statement (annual, 2024-12-31) — EBITDA: -187000000.00
RXO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -2000000.00
RXO cash_flow (annual, 2024-12-31) — End Cash Position: 35000000.00
RXO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 1108000000.00
RXO cash_flow (annual, 2024-12-31) — Free Cash Flow: -57000000.00
RXO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -10000000.00
RXO balance_sheet (annual, 2024-12-31) — Goodwill: 1123000000.00
RXO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1622000000.00
RXO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 1240000000.00
RXO balance_sheet (annual, 2024-12-31) — Gross PPE: 728000000.00
RXO income_statement (annual, 2024-12-31) — Gross Profit: 696000000.00
RXO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
RXO cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 4000000.00
RXO income_statement (annual, 2024-12-31) — Interest Expense: 30000000.00
RXO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 30000000.00
RXO cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 27000000.00
RXO balance_sheet (annual, 2024-12-31) — Invested Capital: 1980000000.00
RXO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1064000000.00
RXO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 1125000000.00
RXO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
RXO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 238000000.00
RXO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 215000000.00
RXO balance_sheet (annual, 2024-12-31) — Long Term Debt: 351000000.00
RXO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 566000000.00
RXO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 238000000.00
RXO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -229000000.00
RXO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 382000000.00
RXO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 382000000.00
RXO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -1019000000.00
RXO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 1125000000.00
RXO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
RXO balance_sheet (annual, 2024-12-31) — Net Debt: 333000000.00
RXO income_statement (annual, 2024-12-31) — Net Income: -290000000.00
RXO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -290000000.00
RXO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -290000000.00
RXO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -290000000.00
RXO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -290000000.00
RXO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -290000000.00
RXO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -290000000.00
RXO income_statement (annual, 2024-12-31) — Net Interest Income: -30000000.00
RXO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 9000000.00
RXO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 9000000.00
RXO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -30000000.00
RXO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -26000000.00
RXO balance_sheet (annual, 2024-12-31) — Net PPE: 411000000.00
RXO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -45000000.00
RXO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -10000000.00
RXO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 88000000.00
RXO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 88000000.00
RXO income_statement (annual, 2024-12-31) — Normalized EBITDA: -101000000.00
RXO income_statement (annual, 2024-12-31) — Normalized Income: -207956000.00
RXO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -12000000.00
RXO income_statement (annual, 2024-12-31) — Operating Income: 30000000.00
RXO income_statement (annual, 2024-12-31) — Operating Revenue: 4550000000.00
RXO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 162517000.00
RXO balance_sheet (annual, 2024-12-31) — Other Current Assets: 77000000.00
RXO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 17000000.00
RXO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 26000000.00
RXO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -10000000.00
RXO income_statement (annual, 2024-12-31) — Other Income Expense: -304000000.00
RXO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 499000000.00
RXO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 223000000.00
RXO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 42000000.00
RXO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 83000000.00
RXO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -218000000.00
RXO income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -1000000.00
RXO balance_sheet (annual, 2024-12-31) — Other Properties: 276000000.00
RXO balance_sheet (annual, 2024-12-31) — Payables: 568000000.00
RXO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 941000000.00
RXO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
RXO income_statement (annual, 2024-12-31) — Pretax Income: -304000000.00
RXO cash_flow (annual, 2024-12-31) — Purchase Of Business: -1019000000.00
RXO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -45000000.00
RXO balance_sheet (annual, 2024-12-31) — Receivables: 1227000000.00
RXO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 3854000000.00
RXO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 87000000.00
RXO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -229000000.00
RXO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
RXO cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
RXO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 86000000.00
RXO balance_sheet (annual, 2024-12-31) — Retained Earnings: -284000000.00
RXO cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
RXO income_statement (annual, 2024-12-31) — Selling General And Administration: 666000000.00
RXO balance_sheet (annual, 2024-12-31) — Share Issued: 162517000.00
RXO income_statement (annual, 2024-12-31) — Special Income Charges: -86000000.00
RXO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 23000000.00
RXO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1612000000.00
RXO balance_sheet (annual, 2024-12-31) — Tangible Book Value: -10000000.00
RXO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -3956000.00
RXO income_statement (annual, 2024-12-31) — Tax Provision: -14000000.00
RXO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.05
RXO balance_sheet (annual, 2024-12-31) — Total Assets: 3414000000.00
RXO balance_sheet (annual, 2024-12-31) — Total Capitalization: 1963000000.00
RXO balance_sheet (annual, 2024-12-31) — Total Debt: 664000000.00
RXO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1612000000.00
RXO income_statement (annual, 2024-12-31) — Total Expenses: 4520000000.00
RXO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1802000000.00
RXO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 2075000000.00
RXO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 737000000.00